Chris Garabedian
PersonHeard in 1 episode across 1 show since Oct 2026
Chris Garabedian is a life sciences executive, investor, and entrepreneur. He is the CEO of Xontogeny and a portfolio manager at PXV Funds, with a biopharmaceutical career that includes work at Sarepta Therapeutics, Celgene, and Gilead Sciences.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
Email alert
Email me when Chris Garabedian comes up on a podcast
One email a week at most, with the new episodes that mention Chris Garabedian. Free, no account needed, unsubscribe in one click.
What Chris Garabedian has said on podcasts
2 statements
The biotech market will resume a healthier trajectory after current difficulties.
“I'm predicting that we'll resume with kind of a healthy market”
Open the episode · Episode 200 - October 23, 2026Listen at 22:33
“AI is not going to live up to the current hype fully”
Open the episode · Episode 200 - October 23, 2026Listen at 57:44
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Chris Garabedian, newest first
